Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Dianovator AB on directed share issue
Mandate

Vinge advises Dianovator AB on directed share issue

September 15, 2017

Vinge has advised Dianovator AB in connection with a directed share issue to finance the company’s research and development.

Dianovator AB is developing a patient-specific decision support system for improved glycemic control by optimized insulin dosing.

Dianovator AB was assisted by Kristoffer Franzkeit.

Related

Vinge advises Precise Biometrics in connection with rights issue
July 24, 2026

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

 Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

 Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026